ACADIA Pharmaceuticals Inc (ACAD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD)

ACAD 25.44

+2.3%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: scaram(o)uche	4/17/2005 11:39:23 AM
	of 588

TREATING NEUROPATHIC PAIN WITH NEUROPEPTIDE FF RECEPTOR 2 AGONISTS Patent number: WO2005031000 Publication date: 2005-04-07 Inventor: SCULLY AUDRA L [US]; DAVIS ROBERT E [US]; VANOVER KIMBERLY E [US]; GARDELL LUIS ROBERTO [US]; LAMEH JELVEH [US]; KELLY NICHOLAS MICHAEL [DK]; BERTOZZI FABIO [DK] Applicant: ACADIA PHARM INC [US];; SCULLY AUDRA L [US];; DAVIS ROBERT E [US];; VANOVER KIMBERLY E [US];; GARDELL LUIS ROBERTO [US];; LAMEH JELVEH [US];; KELLY NICHOLAS MICHAEL [DK];; BERTOZZI FABIO [DK] Application number: WO2004US31530 20040924 Priority number(s): US20030506130P 20030925; US20030508008P 20031002 Abstract of WO2005031000 The invention described below relates to the discovery of the neuropeptide FF receptor subtype that mediates acute nociception and chronic neuropathic pain, compounds that selectively interact with this receptor subtype and methods for treating acute pain and chronic neuropathic pain.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next